Health-related quality of life: Let's measure and report it appropriately

Clinical Therapeutics

Volumn 29, Issue 12, 2007, Pages 2746-2747

  Coons, Stephen Joel ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EDITORIAL; FOOD AND DRUG ADMINISTRATION; PHARMACIST; QUALITY OF LIFE; WELLBEING;

EID: 38049029067     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2007.12.031     Document Type: Article

References (11)

1. Baker D., and Feagan B. Deciphering the Crohn's disease conundrum: Clinical impact and management. J Manag Care Contin Ed (September 2007) 11
2. Burke L. Acceptable evidence for pharmaceutical advertising and labeling. DIA Workshop on Pharmacoeconomic and Quality of Life Labeling and Marketing Claims (October 3, 2000-December 10, 2007). http://www.fda.gov/cder/ddmac/brkIDIA1000/tsld001.htm Accessed
3. US Food and Drug Administration. Draft Guidance for Industry. Patient-reported outcome measures: Use in medical product development to support labeling claims. February 2006 (December 10, 2007). http://www.fda.gov/cder/guidance/5460dft.htm Accessed
4. Acquadro C., Berzon R., Dubois D., et al., PRO Harmonization Group. Incorporating the patient's perspective into drug development and communication: An ad hoc task force report of the Patient-Reported Outcomes (PRO) Harmonization Group meeting at the Food and Drug Administration, February 16, 2001. Value Health 6 (2003) 521-533
5. Wiklund I. Assessment of patient-reported outcomes in clinical trials: The example of health-related quality of life. Fundam Clin Pharmacol 18 (2004) 351-363
6. Szende A., Leidy N., and Revicki D. Health-related quality of life and other patient-reported outcomes in the European centralized drug regulatory process: A review of guidance documents and performed authorizations of medicinal products 1995 to 2003. Value Health 8 (2005) 534-548
7. Revicki D., Gnanasakthy A., and Weinfurt K. Documenting the rationale and psychometric characteristics of patient reported outcomes for labeling and promotional claims: The PRO Evidence Dossier. Qual Life Res 16 (2007) 717-723
8. Patrick D., Burke L., Powers J., et al. Patient-reported outcomes to support medical product labeling claims: FDA perspective. Value Health 10 Suppl 2 (2007) S125-S137
9. Revicki D., Osoba D., Fairclough D., et al. Recommendations on health-related quality of life research to support labeling and promotional claims in the United States. Qual Life Res 9 (2000) 888
10. European Medicines Agency. Reflection paper on the regulatory guidance for the use of health-related quality of life (HRQL) measures in the evaluation of medicinal products. July 27, 2005 (December 10, 2007). http://www.emea.eu.int/pdfs/human/ewp/13939104en.pdf Accessed
11. Willke R., Burke L., and Erickson P. Measuring treatment impact: A review of patient-reported outcomes and other efficacy endpoints in approved product labels. Control Clin Trials 25 (2004) 535-552